Leading American and Russian endocrinologists hold joint meeting

A delegation of the nation's leading endocrinologists are in Moscow, Russia, this week for a historic joint meeting with the Russian Endocrinology Society. Representatives from the American Association of Clinical Endocrinologists (AACE) will present new information in the field of endocrinology at the Third Congress in Endocrinology, May 25-28.

"The conference is the first joint meeting of Russian and American endocrinology organizations," states Paul S. Jellinger, MD, MACE, president of the American College of Endocrinology (ACE), AACE's educational arm. "The global rise of endocrine-related disorders, such as diabetes and obesity, has made it more important than ever to share new research on an international level."

AACE experts will present new information on diabetes, hyperglycemia, islet cell transplantation, thyroid and osteoporosis. Over 650 endocrinologists are expected to attend the four-day conference.

In efforts to broaden endocrine education internationally, AACE has jointly sponsored over a dozen meetings since 2001 with international endocrine organizations in countries such as Italy, Turkey, Mexico, Brazil, Romania and Egypt. At present, fifteen percent of AACE's membership is made up of international endocrinologists.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
SGLT2 inhibitor canagliflozin shown to improve kidney oxygenation in diabetes patients